A class of drugs commonly given to children undergoing tonsillectomy is not likely to increase the risk of serious bleeding after surgery, according to a new U.S. study. Christopher Hartnick, HMS professor of otology and laryngology at Massachusetts Eye and Ear Infirmary, is a co-author of the study.
News & Research
